JP Morgan Chase
CLB icon

JP Morgan Chase’s Core Laboratories CLB Stock Holding History

JP Morgan Chase’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$389K Buy
23,192
+4
+0% +$72 ﹤0.01% 5167
2025
Q4 		$372K Buy
23,188
+1,023
+5% +$15.2K ﹤0.01% 5209
2025
Q3 		$274K Sell
22,165
-3,577
-14% -$41.9K ﹤0.01% 5344
2025
Q2 		$297K Sell
25,742
-18,220
-41% -$216K ﹤0.01% 5038
2025
Q1 		$659K Sell
43,962
-64,066
-59% -$1.07M ﹤0.01% 4610
2024
Q4 		$1.87M Buy
108,028
+66,747
+162% +$1.29M ﹤0.01% 4206
2024
Q3 		$765K Buy
41,281
+2,267
+6% +$45.5K ﹤0.01% 4633
2024
Q2 		$792K Buy
39,014
+3,901
+11% +$69K ﹤0.01% 4417
2024
Q1 		$600K Sell
35,113
-25,243
-42% -$397K ﹤0.01% 4679
2023
Q4 		$1.07M Sell
60,356
-250
-0.4% -$5.04K ﹤0.01% 4286
2023
Q3 		$1.46M Sell
60,606
-6,041
-9% -$148K ﹤0.01% 3799
2023
Q2 		$1.55M Buy
66,647
+42,254
+173% +$956K ﹤0.01% 3728
2023
Q1 		$538K Buy
24,393
+2,898
+13% +$67.8K ﹤0.01% 4451
2022
Q4 		$436K Buy
21,495
+2,630
+14% +$51K ﹤0.01% 4607
2022
Q3 		$255K Buy
18,865
+9
+0% +$152 ﹤0.01% 4828
2022
Q2 		$374K Sell
18,856
-49,156
-72% -$1.31M ﹤0.01% 4735
2022
Q1 		$2.15M Sell
68,012
-93,517
-58% -$2.62M ﹤0.01% 3693
2021
Q4 		$3.6M Buy
161,529
+110,894
+219% +$2.89M ﹤0.01% 3332
2021
Q3 		$1.41M Sell
50,635
-82,184
-62% -$2.5M ﹤0.01% 4054
2021
Q2 		$5.17M Buy
132,819
+62,476
+89% +$2.24M ﹤0.01% 3016
2021
Q1 		$2.02M Buy
70,343
+56,148
+396% +$1.92M ﹤0.01% 3714
2020
Q4 		$377K Sell
14,195
-19,759
-58% -$403K ﹤0.01% 4530
2020
Q3 		$541K Sell
33,954
-179,792
-84% -$3.77M ﹤0.01% 3945
2020
Q2 		$4.34M Sell
213,746
-626,796
-75% -$11.2M ﹤0.01% 2558
2020
Q1 		$8.69M Sell
840,542
-713,829
-46% -$20M ﹤0.01% 1858
2019
Q4 		$58.6M Buy
1,554,371
+142,198
+10% +$6.39M 0.01% 883
2019
Q3 		$65.8M Buy
1,412,173
+190,026
+16% +$8.83M 0.01% 820
2019
Q2 		$62.6M Buy
1,222,147
+21,810
+2% +$1.28M 0.01% 865
2019
Q1 		$82.7M Sell
1,200,337
-8,616
-0.7% -$578K 0.02% 724
2018
Q4 		$72.1M Sell
1,208,953
-97,715
-7% -$8.43M 0.02% 745
2018
Q3 		$151M Buy
1,306,668
+53,986
+4% +$6.09M 0.03% 541
2018
Q2 		$158M Buy
1,252,682
+73,251
+6% +$8.92M 0.03% 507
2018
Q1 		$128M Buy
1,179,431
+100,435
+9% +$11.1M 0.03% 543
2017
Q4 		$118M Buy
1,078,996
+143,301
+15% +$14.3M 0.02% 578
2017
Q3 		$91.9M Buy
935,695
+121,553
+15% +$11.8M 0.02% 654
2017
Q2 		$82.4M Buy
814,142
+177,077
+28% +$19.1M 0.02% 699
2017
Q1 		$73.6M Buy
637,065
+248,097
+64% +$28.8M 0.02% 750
2016
Q4 		$46.7M Buy
388,968
+365,760
+1,576% +$40.5M 0.01% 932
2016
Q3 		$2.61M Sell
23,208
-18,863
-45% -$2.17M ﹤0.01% 2646
2016
Q2 		$5.21M Buy
42,071
+6,995
+20% +$844K ﹤0.01% 2263
2016
Q1 		$3.94M Buy
35,076
+740
+2% +$76.9K ﹤0.01% 2344
2015
Q4 		$3.73M Buy
34,336
+455
+1% +$52.1K ﹤0.01% 2399
2015
Q3 		$3.38M Sell
33,881
-2,161
-6% -$235K ﹤0.01% 2478
2015
Q2 		$4.11M Sell
36,042
-46,764
-56% -$5.67M ﹤0.01% 2513
2015
Q1 		$8.65M Buy
82,806
+17,265
+26% +$1.84M ﹤0.01% 1995
2014
Q4 		$7.89M Buy
65,541
+14,680
+29% +$1.93M ﹤0.01% 2108
2014
Q3 		$7.44M Buy
50,861
+15,957
+46% +$2.46M ﹤0.01% 2113
2014
Q2 		$5.83M Sell
34,904
-3,498
-9% -$622K ﹤0.01% 2000
2014
Q1 		$7.62M Sell
38,402
-2,061
-5% -$389K ﹤0.01% 1864
2013
Q4 		$7.73M Sell
40,463
-12,429
-23% -$2.31M ﹤0.01% 1907
2013
Q3 		$8.95M Buy
52,892
+2,191
+4% +$340K ﹤0.01% 1823
2013
Q2 		$7.69M Buy
+50,701
New +$7.18M ﹤0.01% 1843

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's CLB Position: Q1 2026 in Review

JP Morgan Chase increased its Core Laboratories (CLB) stake by 0.02% in Q1 2026, buying an estimated $72 and bringing the position to 23,192 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #5167.

JP Morgan Chase first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $158M in Q2 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • JP Morgan Chase held 23,192 shares of Core Laboratories worth $389K as of Q1 2026.
  • JP Morgan Chase bought 4 Core Laboratories shares in Q1 2026, an estimated $72.
  • Core Laboratories made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5167 holding.
  • JP Morgan Chase first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Core Laboratories position peaked at $158M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.